Riskpilot← Back to searchSign inGet full accessApoPharma Oy
OYDissolvedY-tunnus 2160731-1Valkeisentie 99Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20070 employees
Revenue 2024
EUR 0
EBITDA margin
—
+2% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
EUR -8K
-172% vs 2023
| Revenue | EUR 0 | — |
| EBITDA | EUR -14K | +2% |
| Net profit | EUR -8K | -172% |
| Total assets | EUR 421K | -10% |
| Equity | EUR 421K | -10% |
| Employees | 0 | — |
Legal name
ApoPharma Oy
Y-tunnus number
2160731-1
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
3. joulukuuta 2007
Share capital
EUR 2 500
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin
Company purpose
Yhtiön toimialana on lääketieteellisten ja terveydenhoitoon liittyvien tuotteiden ja tarvikkeiden, kemikalio-, rohdos- ja luontaistuotteiden ja kosmetiikan vähittäis- ja tukkumyynti, tuonti, vienti ja valmistus ja lisäksi työvoiman sekä koneiden, laitteiden, kalusteiden, asuin- ja liikekiinteistöjen sekä huoneistojen vuokraus. Yhtiö voi myös omistaa ja hallita arvopapereita, kiinteää ja irtainta omaisuutta, ostaa ja myydä arvopapereita, ostaa ja myydä asunto- ja kiinteistöyhtiön osakkeita sekä asuin- ja liikekiinteistöjä. Yhtiön toimialaan kuuluu myös lääke- ja apteekkialaan liittyvä konsultointi, tuotekehitys ja markkinointipalvelujen myynti.
Address
Valkeisentie 99
Phone
+3580400297110
Email
pirjo.makela@apteekit.net
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 94 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −7 | — | — | — | −0 | −0 |
| EBITDA | 8 | −12 | −17 | −12 | −15 | −14 |
| Depreciation & amort. | — | — | — | — | −0 | −0 |
| EBIT | 8 | −12 | −17 | −12 | −15 | −14 |
| Net financials | 0 | 0 | 1 | 2 | 25 | 7 |
| Profit before tax | 8 | −12 | −16 | −10 | 10 | −8 |
| Tax | 2 | 0 | −0 | −0 | −0 | −0 |
| Net profit | 7 | −12 | −16 | −10 | 10 | −8 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 705 | 664 | 549 | 535 | 466 | 421 |
| Equity | 680 | 613 | 549 | 495 | 466 | 421 |
| Long-term debt | — | — | — | — | 0 | 0 |
| Short-term debt | 25 | 50 | 0 | 41 | 0 | 0 |
| Total debt | 25 | 50 | 0 | 41 | 0 | 0 |
EBITDA margin
-1429000.0%
This company
15.8%
Market median
-9044404% vs market
20192024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20192024
Return on equity
-1.8%
This company
18.4%
Market median
-110% vs market
20192024
Net profit margin
-750900.0%
This company
8.1%
Market median
-9270470% vs market
20192024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20192024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TO Deputy Member | Deputy Member | 2008 | — | — |
PI Chief Executive Officer | Chief Executive Officer | 2008 | — | — |
JF Audit | Audit | 2017 | — | — |
HJ Deputy auditor | Deputy auditor | 2017 | — | — |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ApoPharma Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tapio Olavi Mäkelä | Deputy Member | 0 companies |
| Pirjo Irmeli Mäkelä | Chief Executive Officer | 0 companies |
| Johan-Erik Fant | Audit | 0 companies |
| Hans Jan Anders Jåfs | Deputy auditor | 0 companies |